Literature DB >> 16627733

Oseltamivir becomes plentiful--but still not cheap.

Martin Enserink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16627733     DOI： 10.1126/science.312.5772.382

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  6 in total

1.  Residue-based design of small molecule inhibitor for H1N1, H5N1 and H7N1 mutants.

Authors:  Weng Ieong Tou; Kun-Lung Chang; Tung-Ti Chang; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  J Mol Model       Date:  2015-12-08       Impact factor: 1.810

Review 2.  Priority setting for pandemic influenza: an analysis of national preparedness plans.

Authors:  Lori Uscher-Pines; Saad B Omer; Daniel J Barnett; Thomas A Burke; Ran D Balicer
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

Review 3.  Anti-influenza virus agents: synthesis and mode of action.

Authors:  Irene M Lagoja; Erik De Clercq
Journal:  Med Res Rev       Date:  2008-01       Impact factor: 12.944

Review 4.  Major issues and challenges of influenza pandemic preparedness in developing countries.

Authors:  Hitoshi Oshitani; Taro Kamigaki; Akira Suzuki
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

5.  Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers.

Authors:  Josefina García; Merly Sovero; Alberto L Torres; Jorge Gomez; Richard Douce; Melvin Barrantes; Felix Sanchez; Mirna Jimenez; Guillermo Comach; Ivette de Rivera; Roberto Agudo; Tadeusz Kochel
Journal:  Influenza Other Respir Viruses       Date:  2009-03       Impact factor: 4.380

6.  Neuraminidase Inhibitors in Influenza Treatment and Prevention⁻Is It Time to Call It a Day?

Authors:  César Parra-Rojas; Van Kinh Nguyen; Gustavo Hernandez-Mejia; Esteban A Hernandez-Vargas
Journal:  Viruses       Date:  2018-08-25       Impact factor: 5.048
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.